New metastatic model of human small‐cell lung cancer by orthotopic transplantation in mice
Open Access
- 26 February 2015
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 106 (4) , 367-374
Abstract
Small‐cell lung cancer (SCLC) is an aggressive cancer with high metastatic ability and novel strategies against the metastasis are urgently needed to improve SCLC treatment. However, the mechanism of metastasis of SCLC remains largely to be elucidated. For further studies of SCLC metastasis, we developed a new orthotopic transplantation model in mice. We established a GFP‐labeled subline from the human SCLC cell line DMS273 and transplanted them orthotopically into the lung of nude mice with Matrigel. The GFP‐labeled cells showed significant metastatic activity and formed metastatic foci in distant tissues such as bone, kidney, and brain, as observed in SCLC patients. From a bone metastasis focus of the mouse, we isolated another subline, termed G3H, with enhanced metastatic potential and higher hepatocyte growth factor (HGF) expression than the parental line. Further studies indicated that the HGF/MET signaling pathway was involved in in vitro motility and invasion activities of the G3H cells and treatments with MET inhibitors decreased formation of distant metastases in our orthotopic model using G3H cells. These data indicated that our model mimics the clinical aspect of SCLC such as metastatic tropism and autocrine of HGF/MET signaling. Compared with other orthotopic SCLC models, our model has a superior ability to form distant metastases. Therefore, our model will provide a valuable tool for the study of SCLC metastasis.Keywords
Funding Information
- Japan Society for the Promotion of Science (23790452, 26460481)
This publication has 26 references indexed in Scilit:
- Targeting MET: why, where and how?Current Opinion in Pharmacology, 2013
- Novel strategies for the treatment of small-cell lung carcinomaNature Reviews Clinical Oncology, 2011
- Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasionBritish Journal of Cancer, 2007
- Fast, hungry and unstable: finding the Achilles’ heel of small-cell lung cancerTrends in Molecular Medicine, 2007
- Haptoglobin alpha-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in small cell lung cancer.2004
- c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.2003
- Transcriptional gene expression profiling of small cell lung cancer cells.2003
- Small Cell Lung Carcinoma (SCLC)American Journal of Surgical Pathology, 2002
- Serum hepatocyte growth factor/scatter factor levels in small cell lung cancer patientsLung Cancer, 1997
- ESTABLISHMENT AND IDENTIFICATION OF SMALL CELL LUNG-CANCER CELL-LINES HAVING CLASSIC AND VARIANT FEATURES1985